Fresenius Medical Care | FME - Umsatzerlöse

Aktienkurs
40.25
Täglich Wechseln
1.14 2.91%
Monatlich
1.23%
Jährlich
-0.45%
Q2 Prognose
37.54




Der Umsatz Veränderung Datum
Akzo Nobel EUR 2.37B 180M 2025-12
Alcon AG USD 2.7B 110M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Bayer EUR 11.44B 1.78B 2025-12
Beiersdorf EUR 2.31B 40M 2025-12
DaVita Healthcare Partners USD 3.62B 200M 2025-12
Demant DKK 6.26B 810M 2025-12
E.ON EUR 21.19B 5.23B 2025-12
Essilor EUR 14.47B 7.6B 2025-12
Fresenius EUR 5.88B 400M 2025-12
Fresenius Medical Care EUR 5.07B 180M 2025-12
Genmab DKK 1.06B 36M 2025-12
Getinge SEK 11.07B 3.2B 2024-12
Givaudan CHF 3.61B 256M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
GN Store Nord DKK 4.68B 720M 2025-12
GRIFOLS EUR 1.98B 110M 2025-12
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.25B 70M 2025-12
Novartis USD 13.86B 50M 2025-12
Philips EUR 5.1B 797M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
RWE EUR 4.56B 1.35B 2025-12
Sanofi EUR 11.3B 1.13B 2025-12
SAP EUR 9.68B 600M 2025-12
Smith & Nephew USD 3.18B 353M 2025-12